Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders (Review)

  • Authors:
    • Prince Amoah Barnie
    • Pan Zhang
    • Hongxiang Lv
    • Dan Wang
    • Xiaolian Su
    • Zhaoliang Su
    • Huaxi Xu
  • View Affiliations

  • Published online on: December 30, 2016     https://doi.org/10.3892/etm.2016.4018
  • Pages: 378-388
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Myeloid-derived suppressor cells (MDSCs) were originally described as a heterogeneous population of immature cells derived from myeloid progenitors with immune‑suppressive functions in tumor‑bearing hosts. In recent years, increasing number of studies have described various populations of myeloid cells with MDSC-like properties in murine models of cancer and autoimmune diseases. These studies have observed that the populations of MDSCs are increased during inflammation and autoimmune conditions. In addition, MDSCs can effectively suppress T cell responses and modulate the activity of natural killer cells and other myeloid cells. MDSCs have also been implicated in the induction of regulatory T cell production. Furthermore, these cells have the potential to suppress the autoimmune response, thereby limiting tissue injury. Myeloid regulatory cells (Mregs) are recently attracting increasing attention, since they function in proinflammatory and immune suppression in autoimmune diseases, as well as in various types of cancer. Currently, research focus is directed from MDSCs to Mregs in cancer and autoimmune diseases. The present study reviewed the suppressive roles of MDSCs in various autoimmune murine models, the immune modulation of MDSCs to T helper 17 lymphocytes, as well as the proinflammatory and immunosuppressive roles of Mregs in various types of cancer and autoimmune diseases.

Related Articles

Journal Cover

February 2017
Volume 13 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Barnie, P.A., Zhang, P., Lv, H., Wang, D., Su, X., Su, Z., & Xu, H. (2017). Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders (Review). Experimental and Therapeutic Medicine, 13, 378-388. https://doi.org/10.3892/etm.2016.4018
MLA
Barnie, P. A., Zhang, P., Lv, H., Wang, D., Su, X., Su, Z., Xu, H."Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders (Review)". Experimental and Therapeutic Medicine 13.2 (2017): 378-388.
Chicago
Barnie, P. A., Zhang, P., Lv, H., Wang, D., Su, X., Su, Z., Xu, H."Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders (Review)". Experimental and Therapeutic Medicine 13, no. 2 (2017): 378-388. https://doi.org/10.3892/etm.2016.4018